US · Healthcare

South American Gold Corp (SAGD)

Drug Manufacturers - Specialty & Generic

South American Gold Corp (SAGD) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for SAGD

P/E ratio
18.00

South American Gold Corp (SAGD) — FAQ

What is SAGD's P/E ratio?

The price-to-earnings (P/E) ratio for South American Gold Corp (SAGD) is 18.00 (data as of 2026-05-23).

Does South American Gold Corp pay a dividend?

Dividend yield is not available in the current snapshot for South American Gold Corp (SAGD). Check the MyAverix Finance app for the latest dividend data.

What sector is South American Gold Corp in?

South American Gold Corp (SAGD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is SAGD listed on?

SAGD is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play